Time

Track 1

Track 2

DAY 1, May 24

7:00 AM

Registration, Exhibition and Networking
Breakfast provided

8:00 AM


Opening Words
Ralph Snyderman, Duke University
Tal Behar, PMWC Intl
Geoff Ginsburg, Duke University
Mary E. Klotman, Duke University School of Medicine
Roy Cooper, Governor, NC
Sessions:

An Update on All of Us (PMI)

8:45 AM

Francis Collins, NIH (Federal)

9:15 AM

Geoff Ginsburg, Duke University (State)

Sessions:

Status Quo of Genome Sequencing in Cancer & Beyond

Automating Evidence-based Gene Panel Design

9:30 AM

Charles M. Perou, GeneCentric Diagnostics
Sequencing Studies for Gene Expression Analysis
Mark J. Kiel, Genomenon
Victor Weigman, Q2 Solutions

9:45 AM

Vandana Shashi, Duke University School of Medicine
Undiagnosed Diseases: Resolving one Diagnosis at a Time
Session continued

10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Informed Health Decisions Through Creating a Learning Ecosystem

Cancer Immunotherapy

10:30 AM

Kenneth J. Pienta, Johns Hopkins University
Opening words by session chair
Scott L. Zeger, Johns Hopkins University
Hopkins inHealth: A Model for Individualized Healthcare
Charles Nicolette, Argos Therapeutics

10:45 AM

Ballentine Carter, Johns Hopkins University
Active Surveillance: Individualizing Prostate Cancer Care
Alexis Borisy , Third Rock Ventures
Putting the Precision Oncology and I/O Pieces Together
Sessions:

Recent Developments in Cancer Immunology & Immuno-therapy

IT Solutions in Support of Molecular and Genetics Labs

11:00 AM

Chris Boshoff, Pfizer
Cancer Immuno-therapy: Science Driving Combinatorial Strategies
Chris Callahan, Sunquest
Paul Lang, MedCompGx

11:15 AM

Matthias Gromeier, Duke University Medical Center
Cancer Immuno-therapy with Oncolytic Poliovirus
Session continued
Sessions:

Accelerating Clinical Trials Using Compre-hensive Liquid Biopsy

Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost

11:30 AM

Daniel Simon, Guardant Health
Opening words by session chair
Stuart Goldberg, Cota Healthcare Inc.
Thomas Graf, Horizon BCBSNJ

11:45 AM

John Strickler, Duke Cancer Institute
Optimizing the Use of ctDNA to Accelerate Clinical Discoveries
Session continued

12:00 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Sessions:

Data Science to Advance Precision Medicine

Trends in Compre-hensive Study and Biological Sample Management

1:00PM

Eric Schadt, Icahn School of Medicine
Deriving Personalized Health Insights from the Fusion of Molecular and Digital Biomarkers
Andrew Brooks, Bioprocessing Solutions Alliance

1:15 PM

Jeffrey Rogers, IBMJennifer A. Cheeseman, Duke University
Sessions:

Metabolomics and its Role in Precision Medicine

Session continued

1:30 PM

John Ryals, Metabolon
Christopher Ianelli, iSpecimen
Finding Patients and Specimens to Drive Precision Research

1:45 PM

John Ryals, Metabolon- continuedPodium Presentation: Barrett Bready, Nabsys
Whole Genome Mapping… Now in HD
Sessions:

Infrastructure and Computational Tools in Support of Research and Genomic Medicine

Why Subsets are the Practice

2:00 PM

Elaine R. Mardis, Nationwide Children’s Hospital
Precision Cancer Genomics
Scott L. Zeger, Johns Hopkins University
Opening words by session chair

2:15 PM

Stacey Gabriel, Broad Institute of MIT and Harvard
To the Cloud(s): Keeping up with DNA Sequencing
Antony Rosen, Johns Hopkins Medicine
Rheumatic Disease Autoantibodies: Precision Medicine’s Rosetta Stone
Sessions:

Mobile Health is Changing Healthcare

A Discussion on Increasing Patient Access To Investigational Drugs

2:30 PM

Eric Perakslis, Takeda Pharma
Strategies for Delivering Value from Digital Technology Transformation
Moderator: Ralph Snyderman, Duke University
Ellen V. Sigal, Friends of Cancer Research
Patient Advocacy Role in the Development of the 21 Century Cures Act

2:45 PM

John David Nolen, Cerner Corporation
The Role of Interoperability of Patient Data in Precision Medicine
Marty Tenenbaum, Cancer Commons
Is An Additional Path to FDA Approval Possible

3:00 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Human Genomics is Fuelling Drug Discovery

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

3:30 PM

Rick Dewey, Regeneron
Opening words by session chair
Zaher Nahle, Solve ME/CFS Initiative
Opening words by session chair

3:45 PM

Lon Cardon, GSK
From Genes to Drug Targets
Anthony L. Komaroff, Harvard Medical School

4:00 PM

Michael Murray, Geisinger Medical Center
GenomeFIRST and Risk-Based Healthcare
John Nicols, Codexis

4:15 PM

Novel Approaches to Infectious Disease Diagnosis


Christopher W. Woods, Duke University
Developing Host Response Signatures for Bacterial and Viral Diseases
Q&A
Sessions:

Leaders in Academia and Industry to Foster Biotechnology

Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology

4:30 PM

Ralph Snyderman, Duke University
Advancing Precision Medicine into Practice: Clinical Models
Fred Ashbury, Viviphi Ltd.
Howard L. McLeod, Moffitt Cancer Center

4:45 PM

Moderator: Ralph Snyderman, Duke University
Panelists:
Randy Woodson, North Carolina State University
William Roper, UNC
Jack Bailey, GSK
Douglas L. Edgeton, North Carolina Biotechnology Center
Session continued

5:00 PM

Session continues

Track 2 Closing of Day 1

5:30 PM

Track 1 Closing of Day 1

Reception:

Award Reception

6:00 PM

Networking, Hors d'ourves and Wine

7:00 PM

Ralph Snyderman, Duke University
Opening Words

7:05 PM

Honorees inductions to PMWC Awards:
Francis Collins, NIH to PMWC Luminary Award
Keith Yamamoto, UCSF to PMWC Luminary Award
Elaine R. Mardis, Nationwide Children's Hospital to PMWC Luminary Award
Kathy Giusti, Multiple Myeloma Research Foundation to PMWC Pioneer Award
Mark Levin, Third Rock Ventures to PMWC Pioneer Award

8:00 PM

Closing of Award Ceremony


DAY 2, May 25

Time

Track 1

7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Sessions:

The Value of Data Sharing

8:00 AM

Moderator: Geoff Ginsburg, Duke University
Panelists:
Kathy Giusti, Multiple Myeloma Research Foundation
William (Bill) Dalton, M2Gen
Robert Califf, Duke University
Rick Klausner, Grail

8:30 AM

Session continued

Fireside Chat


Keith Yamamoto, UCSF

8:45 AM

New Trends and Emerging Technologies


Mark Levin, Third Rock Ventures
Nancy Andrews, Duke University

9:00 AM

Mark Levin, Third Rock Ventures- continued
Podium Presentations:
India Hook-Barnard, UCSF
CIAPM: Accelerating Precision Medicine Advances in California

9:15 AM

John Mikszta, BD Genomics
Single Cell Genomics: Emerging Applications
Jane Wilkinson, Broad Genomics Alliance Management
Tackling All Challenges from a Single Sample to Large Clinical Studies

9:30 AM

Lawrence David, Duke University
The Role of the Human Microbiome
Stephen Lyle, KEW Inc.
NGS Testing for Oncology in Community Settings

9:45 AM

Panna Sharma, Cancer Genetics, Inc.
How AI is Accelerating and Enabling Precision Oncology
Amrita Pati, Roche Sequencing Solutions
Overcoming Key Challenges in Liquid Biopsy

10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Liquid Biopsy is Propelling Cancer Diagnostics Research

Podium Presentations Continued

10:30 AM

Rick Klausner, Grail
Industry Overview: Revolutionizing Cancer Screening
Orla O'Hannaidh, Womble Carlyle Sandridge & Rice, LLP
The Legal Landscape: Genetic Information and Privacy Laws in the US

10:45 AM

John Beeler, Inivata
Opening words by session chair
Jose Castro-Perez, Waters Corporation
Mass Spectrometry Advancements in Precision Medicine

11:00 AM

Ed Kim, Levine Cancer Institute
ctDNA in the Routine Management of Cancer Patients: Opportunities and Challenges

Call for Oncologists to Learn About Precision Medicine


Vincent Miller, Foundation Medicine
Opening words by session chair
Sessions:

CRISPR - The Genome Engineering Revolution

Session continued

11:15 AM

Charles Gersbach, Duke University
CRISPR Tools for Gene Therapy and Programming Epigenetics
William Edenfield, Greenville Health System
Sessions:

Delivering Precision Oncology in the Genomics Era

Session continued

11:30 AM

Moderator: Rebecca Brandes, Agilent
Boris Pasche, Wake Forest Baptist Health

11:45 AM

Panelists:
Jennifer Morrissette, Penn Medicine
Nirali Patel, University of North Carolina
Q&A

12:00 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Sessions:

Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role

How Patients Can Advance Precision Medicine and Why You Should Care

1:00 PM

Chris Cournoyer, N-of-One
Opening words by session chair
Moira Quinn, Charlotte Center City Partners
Opening words by session chair

1:15 PM

Anna Berry, CellNetix
Sarah Kerruish, Antidote
Sessions:

Genomics & Precision Medicine in the "Real World"

Session continued

1:30 PM

Jonathan Berg, UNC
Taking Genomic Sequencing from Diagnosis to Screening
Kimberly Blackwell, Duke Cancer Institute

1:45 PM

Amy Abernethy, Flatiron Health
Clinico-Genomics: What is it and Why do we need it?
Nicole Russell, Stage IV Non-Small Cell Lung Cancer Patient
Sessions:

Why Patient Engagement is Important

Podium Presentations Continued

2:00 PM

Moderator: Frank Ingari, CureForward
Benoit Destenaves, AstraZeneca
Approval of the Liquid Biopsy Test for Tagrisso (osimertinib)

2:15 PM

Panelists:
Todd Bauer, Sarah Cannon
Bernadette Tosti, QuintilesIMS
Edison Hudson, Panaceutics Inc.
Beyond Oncology – Data Driven Personalization and Robotics – Potential Impact For Rx Costs
Sessions:

Reforming Clinical Trials

Track 2 Closing of Day 2

2:30 PM

Janet Woodcock, FDA
Sessions:

Reimburse-ments: The Payor Perspective

2:45 PM

Lee Newcomer, UHC
What is The Standard of Care for Personalized Medicine?

3:00 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Approaches towards Understanding and Enhancing Human Longevity

3:30 PM

Brad Perkins, Human Longevity
Precision Medicine Approach to Understanding and Enhancing Human Longevity

3:45 PM

Yaniv Erlich, New York Genome Center
Understanding Longevity Using 86,000,000 Individuals

4:00 PM

Track 1 Closing of Day 2

4:30 PM

Tour of Metabolon. THE TOUR IS FULL & CLOSED

Time

Track 1

Track 2

DAY 1, May 24

7:00 AM

Registration, Exhibition and Networking
Breakfast provided

8:00 AM


Opening Words
Ralph Snyderman, Duke University
Tal Behar, PMWC Intl
Geoff Ginsburg, Duke University
Mary E. Klotman, Duke University School of Medicine
Roy Cooper, Governor, NC
Sessions:

An Update on All of Us (PMI)

8:45 AM

Francis Collins, NIH (Federal)

9:15 AM

Geoff Ginsburg, Duke University (State)

Sessions:

Status Quo of Genome Sequencing in Cancer & Beyond

Automating Evidence-based Gene Panel Design

9:30 AM

Charles M. Perou, GeneCentric Diagnostics
Sequencing Studies for Gene Expression Analysis
Mark J. Kiel, Genomenon
Victor Weigman, Q2 Solutions

9:45 AM

Vandana Shashi, Duke University School of Medicine
Undiagnosed Diseases: Resolving one Diagnosis at a Time
Session continued

10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Informed Health Decisions Through Creating a Learning Ecosystem

Cancer Immunotherapy

10:30 AM

Kenneth J. Pienta, Johns Hopkins University
Opening words by session chair
Scott L. Zeger, Johns Hopkins University
Hopkins inHealth: A Model for Individualized Healthcare
Charles Nicolette, Argos Therapeutics

10:45 AM

Ballentine Carter, Johns Hopkins University
Active Surveillance: Individualizing Prostate Cancer Care
Alexis Borisy , Third Rock Ventures
Putting the Precision Oncology and I/O Pieces Together
Sessions:

Recent Developments in Cancer Immunology & Immuno-therapy

IT Solutions in Support of Molecular and Genetics Labs

11:00 AM

Chris Boshoff, Pfizer
Cancer Immuno-therapy: Science Driving Combinatorial Strategies
Chris Callahan, Sunquest
Paul Lang, MedCompGx

11:15 AM

Matthias Gromeier, Duke University Medical Center
Cancer Immuno-therapy with Oncolytic Poliovirus
Session continued
Sessions:

Accelerating Clinical Trials Using Compre-hensive Liquid Biopsy

Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost

11:30 AM

Daniel Simon, Guardant Health
Opening words by session chair
Stuart Goldberg, Cota Healthcare Inc.
Thomas Graf, Horizon BCBSNJ

11:45 AM

John Strickler, Duke Cancer Institute
Optimizing the Use of ctDNA to Accelerate Clinical Discoveries
Session continued

12:00 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Sessions:

Data Science to Advance Precision Medicine

Trends in Compre-hensive Study and Biological Sample Management

1:00PM

Eric Schadt, Icahn School of Medicine
Deriving Personalized Health Insights from the Fusion of Molecular and Digital Biomarkers
Andrew Brooks, Bioprocessing Solutions Alliance

1:15 PM

Jeffrey Rogers, IBMJennifer A. Cheeseman, Duke University
Sessions:

Metabolomics and its Role in Precision Medicine

Session continued

1:30 PM

John Ryals, Metabolon
Christopher Ianelli, iSpecimen
Finding Patients and Specimens to Drive Precision Research

1:45 PM

John Ryals, Metabolon- continuedPodium Presentation: Barrett Bready, Nabsys
Whole Genome Mapping… Now in HD
Sessions:

Infrastructure and Computational Tools in Support of Research and Genomic Medicine

Why Subsets are the Practice

2:00 PM

Elaine R. Mardis, Nationwide Children’s Hospital
Precision Cancer Genomics
Scott L. Zeger, Johns Hopkins University
Opening words by session chair

2:15 PM

Stacey Gabriel, Broad Institute of MIT and Harvard
To the Cloud(s): Keeping up with DNA Sequencing
Antony Rosen, Johns Hopkins Medicine
Rheumatic Disease Autoantibodies: Precision Medicine’s Rosetta Stone
Sessions:

Mobile Health is Changing Healthcare

A Discussion on Increasing Patient Access To Investigational Drugs

2:30 PM

Eric Perakslis, Takeda Pharma
Strategies for Delivering Value from Digital Technology Transformation
Moderator: Ralph Snyderman, Duke University
Ellen V. Sigal, Friends of Cancer Research
Patient Advocacy Role in the Development of the 21 Century Cures Act

2:45 PM

John David Nolen, Cerner Corporation
The Role of Interoperability of Patient Data in Precision Medicine
Marty Tenenbaum, Cancer Commons
Is An Additional Path to FDA Approval Possible

3:00 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Human Genomics is Fuelling Drug Discovery

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

3:30 PM

Rick Dewey, Regeneron
Opening words by session chair
Zaher Nahle, Solve ME/CFS Initiative
Opening words by session chair

3:45 PM

Lon Cardon, GSK
From Genes to Drug Targets
Anthony L. Komaroff, Harvard Medical School

4:00 PM

Michael Murray, Geisinger Medical Center
GenomeFIRST and Risk-Based Healthcare
John Nicols, Codexis

4:15 PM

Novel Approaches to Infectious Disease Diagnosis


Christopher W. Woods, Duke University
Developing Host Response Signatures for Bacterial and Viral Diseases
Q&A
Sessions:

Leaders in Academia and Industry to Foster Biotechnology

Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology

4:30 PM

Ralph Snyderman, Duke University
Advancing Precision Medicine into Practice: Clinical Models
Fred Ashbury, Viviphi Ltd.
Howard L. McLeod, Moffitt Cancer Center

4:45 PM

Moderator: Ralph Snyderman, Duke University
Panelists:
Randy Woodson, North Carolina State University
William Roper, UNC
Jack Bailey, GSK
Douglas L. Edgeton, North Carolina Biotechnology Center
Session continued

5:00 PM

Session continues

Track 2 Closing of Day 1

5:30 PM

Track 1 Closing of Day 1

Reception:

Award Reception

6:00 PM

Networking, Hors d'ourves and Wine

7:00 PM

Ralph Snyderman, Duke University
Opening Words

7:05 PM

Honorees inductions to PMWC Awards:
Francis Collins, NIH to PMWC Luminary Award
Keith Yamamoto, UCSF to PMWC Luminary Award
Elaine R. Mardis, Nationwide Children's Hospital to PMWC Luminary Award
Kathy Giusti, Multiple Myeloma Research Foundation to PMWC Pioneer Award
Mark Levin, Third Rock Ventures to PMWC Pioneer Award

8:00 PM

Closing of Award Ceremony


DAY 2, May 25

Time

Track 1

7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Sessions:

The Value of Data Sharing

8:00 AM

Moderator: Geoff Ginsburg, Duke University
Panelists:
Kathy Giusti, Multiple Myeloma Research Foundation
William (Bill) Dalton, M2Gen
Robert Califf, Duke University
Rick Klausner, Grail

8:30 AM

Session continued

Fireside Chat


Keith Yamamoto, UCSF

8:45 AM

New Trends and Emerging Technologies


Mark Levin, Third Rock Ventures
Nancy Andrews, Duke University

9:00 AM

Mark Levin, Third Rock Ventures- continued
Podium Presentations:
India Hook-Barnard, UCSF
CIAPM: Accelerating Precision Medicine Advances in California

9:15 AM

John Mikszta, BD Genomics
Single Cell Genomics: Emerging Applications
Jane Wilkinson, Broad Genomics Alliance Management
Tackling All Challenges from a Single Sample to Large Clinical Studies

9:30 AM

Lawrence David, Duke University
The Role of the Human Microbiome
Stephen Lyle, KEW Inc.
NGS Testing for Oncology in Community Settings

9:45 AM

Panna Sharma, Cancer Genetics, Inc.
How AI is Accelerating and Enabling Precision Oncology
Amrita Pati, Roche Sequencing Solutions
Overcoming Key Challenges in Liquid Biopsy

10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Liquid Biopsy is Propelling Cancer Diagnostics Research

Podium Presentations Continued

10:30 AM

Rick Klausner, Grail
Industry Overview: Revolutionizing Cancer Screening
Orla O'Hannaidh, Womble Carlyle Sandridge & Rice, LLP
The Legal Landscape: Genetic Information and Privacy Laws in the US

10:45 AM

John Beeler, Inivata
Opening words by session chair
Jose Castro-Perez, Waters Corporation
Mass Spectrometry Advancements in Precision Medicine

11:00 AM

Ed Kim, Levine Cancer Institute
ctDNA in the Routine Management of Cancer Patients: Opportunities and Challenges

Call for Oncologists to Learn About Precision Medicine


Vincent Miller, Foundation Medicine
Opening words by session chair
Sessions:

CRISPR - The Genome Engineering Revolution

Session continued

11:15 AM

Charles Gersbach, Duke University
CRISPR Tools for Gene Therapy and Programming Epigenetics
William Edenfield, Greenville Health System
Sessions:

Delivering Precision Oncology in the Genomics Era

Session continued

11:30 AM

Moderator: Rebecca Brandes, Agilent
Boris Pasche, Wake Forest Baptist Health

11:45 AM

Panelists:
Jennifer Morrissette, Penn Medicine
Nirali Patel, University of North Carolina
Q&A

12:00 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Sessions:

Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role

How Patients Can Advance Precision Medicine and Why You Should Care

1:00 PM

Chris Cournoyer, N-of-One
Opening words by session chair
Moira Quinn, Charlotte Center City Partners
Opening words by session chair

1:15 PM

Anna Berry, CellNetix
Sarah Kerruish, Antidote
Sessions:

Genomics & Precision Medicine in the "Real World"

Session continued

1:30 PM

Jonathan Berg, UNC
Taking Genomic Sequencing from Diagnosis to Screening
Kimberly Blackwell, Duke Cancer Institute

1:45 PM

Amy Abernethy, Flatiron Health
Clinico-Genomics: What is it and Why do we need it?
Nicole Russell, Stage IV Non-Small Cell Lung Cancer Patient
Sessions:

Why Patient Engagement is Important

Podium Presentations Continued

2:00 PM

Moderator: Frank Ingari, CureForward
Benoit Destenaves, AstraZeneca
Approval of the Liquid Biopsy Test for Tagrisso (osimertinib)

2:15 PM

Panelists:
Todd Bauer, Sarah Cannon
Bernadette Tosti, QuintilesIMS
Edison Hudson, Panaceutics Inc.
Beyond Oncology – Data Driven Personalization and Robotics – Potential Impact For Rx Costs
Sessions:

Reforming Clinical Trials

Track 2 Closing of Day 2

2:30 PM

Janet Woodcock, FDA
Sessions:

Reimburse-ments: The Payor Perspective

2:45 PM

Lee Newcomer, UHC
What is The Standard of Care for Personalized Medicine?

3:00 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Approaches towards Understanding and Enhancing Human Longevity

3:30 PM

Brad Perkins, Human Longevity
Precision Medicine Approach to Understanding and Enhancing Human Longevity

3:45 PM

Yaniv Erlich, New York Genome Center
Understanding Longevity Using 86,000,000 Individuals

4:00 PM

Track 1 Closing of Day 2

4:30 PM

Tour of Metabolon. THE TOUR IS FULL & CLOSED

Program Schedule

Time

Track 1

Track 2

DAY 1, May 24

7:00 AM

Registration, Exhibition and Networking
Breakfast provided

8:00 AM


Opening Words
Ralph Snyderman, Duke University
Tal Behar, PMWC Intl
Geoff Ginsburg, Duke University
Mary E. Klotman, Duke University School of Medicine
Roy Cooper, Governor, NC
Sessions:

An Update on All of Us (PMI)

8:45 AM

Francis Collins, NIH (Federal)

9:15 AM

Geoff Ginsburg, Duke University (State)

Sessions:

Status Quo of Genome Sequencing in Cancer & Beyond

Automating Evidence-based Gene Panel Design

9:30 AM

Charles M. Perou, GeneCentric Diagnostics
Sequencing Studies for Gene Expression Analysis
Mark J. Kiel, Genomenon
Victor Weigman, Q2 Solutions

9:45 AM

Vandana Shashi, Duke University School of Medicine
Undiagnosed Diseases: Resolving one Diagnosis at a Time
Session continued

10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Informed Health Decisions Through Creating a Learning Ecosystem

Cancer Immunotherapy

10:30 AM

Kenneth J. Pienta, Johns Hopkins University
Opening words by session chair
Scott L. Zeger, Johns Hopkins University
Hopkins inHealth: A Model for Individualized Healthcare
Charles Nicolette, Argos Therapeutics

10:45 AM

Ballentine Carter, Johns Hopkins University
Active Surveillance: Individualizing Prostate Cancer Care
Alexis Borisy , Third Rock Ventures
Putting the Precision Oncology and I/O Pieces Together
Sessions:

Recent Developments in Cancer Immunology & Immuno-therapy

IT Solutions in Support of Molecular and Genetics Labs

11:00 AM

Chris Boshoff, Pfizer
Cancer Immuno-therapy: Science Driving Combinatorial Strategies
Chris Callahan, Sunquest
Paul Lang, MedCompGx

11:15 AM

Matthias Gromeier, Duke University Medical Center
Cancer Immuno-therapy with Oncolytic Poliovirus
Session continued
Sessions:

Accelerating Clinical Trials Using Compre-hensive Liquid Biopsy

Value-Based Care Models Increase Patient Outcomes and Lower Healthcare Cost

11:30 AM

Daniel Simon, Guardant Health
Opening words by session chair
Stuart Goldberg, Cota Healthcare Inc.
Thomas Graf, Horizon BCBSNJ

11:45 AM

John Strickler, Duke Cancer Institute
Optimizing the Use of ctDNA to Accelerate Clinical Discoveries
Session continued

12:00 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Sessions:

Data Science to Advance Precision Medicine

Trends in Compre-hensive Study and Biological Sample Management

1:00PM

Eric Schadt, Icahn School of Medicine
Deriving Personalized Health Insights from the Fusion of Molecular and Digital Biomarkers
Andrew Brooks, Bioprocessing Solutions Alliance

1:15 PM

Jeffrey Rogers, IBMJennifer A. Cheeseman, Duke University
Sessions:

Metabolomics and its Role in Precision Medicine

Session continued

1:30 PM

John Ryals, Metabolon
Christopher Ianelli, iSpecimen
Finding Patients and Specimens to Drive Precision Research

1:45 PM

John Ryals, Metabolon- continuedPodium Presentation: Barrett Bready, Nabsys
Whole Genome Mapping… Now in HD
Sessions:

Infrastructure and Computational Tools in Support of Research and Genomic Medicine

Why Subsets are the Practice

2:00 PM

Elaine R. Mardis, Nationwide Children’s Hospital
Precision Cancer Genomics
Scott L. Zeger, Johns Hopkins University
Opening words by session chair

2:15 PM

Stacey Gabriel, Broad Institute of MIT and Harvard
To the Cloud(s): Keeping up with DNA Sequencing
Antony Rosen, Johns Hopkins Medicine
Rheumatic Disease Autoantibodies: Precision Medicine’s Rosetta Stone
Sessions:

Mobile Health is Changing Healthcare

A Discussion on Increasing Patient Access To Investigational Drugs

2:30 PM

Eric Perakslis, Takeda Pharma
Strategies for Delivering Value from Digital Technology Transformation
Moderator: Ralph Snyderman, Duke University
Ellen V. Sigal, Friends of Cancer Research
Patient Advocacy Role in the Development of the 21 Century Cures Act

2:45 PM

John David Nolen, Cerner Corporation
The Role of Interoperability of Patient Data in Precision Medicine
Marty Tenenbaum, Cancer Commons
Is An Additional Path to FDA Approval Possible

3:00 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Human Genomics is Fuelling Drug Discovery

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

3:30 PM

Rick Dewey, Regeneron
Opening words by session chair
Zaher Nahle, Solve ME/CFS Initiative
Opening words by session chair

3:45 PM

Lon Cardon, GSK
From Genes to Drug Targets
Anthony L. Komaroff, Harvard Medical School

4:00 PM

Michael Murray, Geisinger Medical Center
GenomeFIRST and Risk-Based Healthcare
John Nicols, Codexis

4:15 PM

Novel Approaches to Infectious Disease Diagnosis


Christopher W. Woods, Duke University
Developing Host Response Signatures for Bacterial and Viral Diseases
Q&A
Sessions:

Leaders in Academia and Industry to Foster Biotechnology

Opportunities & Lessons Learned Establishing Precision Medicine Programs in Oncology

4:30 PM

Ralph Snyderman, Duke University
Advancing Precision Medicine into Practice: Clinical Models
Fred Ashbury, Viviphi Ltd.
Howard L. McLeod, Moffitt Cancer Center

4:45 PM

Moderator: Ralph Snyderman, Duke University
Panelists:
Randy Woodson, North Carolina State University
William Roper, UNC
Jack Bailey, GSK
Douglas L. Edgeton, North Carolina Biotechnology Center
Session continued

5:00 PM

Session continues

Track 2 Closing of Day 1

5:30 PM

Track 1 Closing of Day 1

Reception:

Award Reception

6:00 PM

Networking, Hors d'ourves and Wine

7:00 PM

Ralph Snyderman, Duke University
Opening Words

7:05 PM

Honorees inductions to PMWC Awards:
Francis Collins, NIH to PMWC Luminary Award
Keith Yamamoto, UCSF to PMWC Luminary Award
Elaine R. Mardis, Nationwide Children's Hospital to PMWC Luminary Award
Kathy Giusti, Multiple Myeloma Research Foundation to PMWC Pioneer Award
Mark Levin, Third Rock Ventures to PMWC Pioneer Award

8:00 PM

Closing of Award Ceremony


DAY 2, May 25

Time

Track 1

7:00 AM

Registration, Exhibition and Networking
Breakfast provided

Sessions:

The Value of Data Sharing

8:00 AM

Moderator: Geoff Ginsburg, Duke University
Panelists:
Kathy Giusti, Multiple Myeloma Research Foundation
William (Bill) Dalton, M2Gen
Robert Califf, Duke University
Rick Klausner, Grail

8:30 AM

Session continued

Fireside Chat


Keith Yamamoto, UCSF

8:45 AM

New Trends and Emerging Technologies


Mark Levin, Third Rock Ventures
Nancy Andrews, Duke University

9:00 AM

Mark Levin, Third Rock Ventures- continued
Podium Presentations:
India Hook-Barnard, UCSF
CIAPM: Accelerating Precision Medicine Advances in California

9:15 AM

John Mikszta, BD Genomics
Single Cell Genomics: Emerging Applications
Jane Wilkinson, Broad Genomics Alliance Management
Tackling All Challenges from a Single Sample to Large Clinical Studies

9:30 AM

Lawrence David, Duke University
The Role of the Human Microbiome
Stephen Lyle, KEW Inc.
NGS Testing for Oncology in Community Settings

9:45 AM

Panna Sharma, Cancer Genetics, Inc.
How AI is Accelerating and Enabling Precision Oncology
Amrita Pati, Roche Sequencing Solutions
Overcoming Key Challenges in Liquid Biopsy

10:00 AM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Liquid Biopsy is Propelling Cancer Diagnostics Research

Podium Presentations Continued

10:30 AM

Rick Klausner, Grail
Industry Overview: Revolutionizing Cancer Screening
Orla O'Hannaidh, Womble Carlyle Sandridge & Rice, LLP
The Legal Landscape: Genetic Information and Privacy Laws in the US

10:45 AM

John Beeler, Inivata
Opening words by session chair
Jose Castro-Perez, Waters Corporation
Mass Spectrometry Advancements in Precision Medicine

11:00 AM

Ed Kim, Levine Cancer Institute
ctDNA in the Routine Management of Cancer Patients: Opportunities and Challenges

Call for Oncologists to Learn About Precision Medicine


Vincent Miller, Foundation Medicine
Opening words by session chair
Sessions:

CRISPR - The Genome Engineering Revolution

Session continued

11:15 AM

Charles Gersbach, Duke University
CRISPR Tools for Gene Therapy and Programming Epigenetics
William Edenfield, Greenville Health System
Sessions:

Delivering Precision Oncology in the Genomics Era

Session continued

11:30 AM

Moderator: Rebecca Brandes, Agilent
Boris Pasche, Wake Forest Baptist Health

11:45 AM

Panelists:
Jennifer Morrissette, Penn Medicine
Nirali Patel, University of North Carolina
Q&A

12:00 PM

Break, Exhibition and Networking
Lunch provided

Break, Exhibition and Networking
Lunch provided

Sessions:

Advancing Precision Medicine in Oncology: The Molecular Pathologist’s Role

How Patients Can Advance Precision Medicine and Why You Should Care

1:00 PM

Chris Cournoyer, N-of-One
Opening words by session chair
Moira Quinn, Charlotte Center City Partners
Opening words by session chair

1:15 PM

Anna Berry, CellNetix
Sarah Kerruish, Antidote
Sessions:

Genomics & Precision Medicine in the "Real World"

Session continued

1:30 PM

Jonathan Berg, UNC
Taking Genomic Sequencing from Diagnosis to Screening
Kimberly Blackwell, Duke Cancer Institute

1:45 PM

Amy Abernethy, Flatiron Health
Clinico-Genomics: What is it and Why do we need it?
Nicole Russell, Stage IV Non-Small Cell Lung Cancer Patient
Sessions:

Why Patient Engagement is Important

Podium Presentations Continued

2:00 PM

Moderator: Frank Ingari, CureForward
Benoit Destenaves, AstraZeneca
Approval of the Liquid Biopsy Test for Tagrisso (osimertinib)

2:15 PM

Panelists:
Todd Bauer, Sarah Cannon
Bernadette Tosti, QuintilesIMS
Edison Hudson, Panaceutics Inc.
Beyond Oncology – Data Driven Personalization and Robotics – Potential Impact For Rx Costs
Sessions:

Reforming Clinical Trials

Track 2 Closing of Day 2

2:30 PM

Janet Woodcock, FDA
Sessions:

Reimburse-ments: The Payor Perspective

2:45 PM

Lee Newcomer, UHC
What is The Standard of Care for Personalized Medicine?

3:00 PM

Break, Exhibition and Networking
Coffee and Refreshments Provided

Sessions:

Approaches towards Understanding and Enhancing Human Longevity

3:30 PM

Brad Perkins, Human Longevity
Precision Medicine Approach to Understanding and Enhancing Human Longevity

3:45 PM

Yaniv Erlich, New York Genome Center
Understanding Longevity Using 86,000,000 Individuals

4:00 PM

Track 1 Closing of Day 2

4:30 PM

Tour of Metabolon. THE TOUR IS FULL & CLOSED